RWS of Inetetamab HER2 Positive Advanced Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: HER2-positive Advanced Breast Cancer
Interventions: DRUG: Inetetamab
Sponsor: Zhiyong Yu